Citadel Advisors - BIONDVAX PHARMACEUTICALS LTD ownership

Back to all holdings Add to watchlist

BIONDVAX PHARMACEUTICALS LTD's ticker is BVXV and the CUSIP is 09073Q105. A total of 20 filers reported holding BIONDVAX PHARMACEUTICALS LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Citadel Advisors ownership history of BIONDVAX PHARMACEUTICALS LTD
ValueSharesWeighting
Q2 2022$28,000
-60.0%
23,844
-43.5%
0.00%–
Q1 2022$70,000
+75.0%
42,225
+133.6%
0.00%–
Q3 2021$40,000
-64.0%
18,076
-38.3%
0.00%–
Q1 2021$111,000
-37.3%
29,300
-4.2%
0.00%–
Q1 2017$177,000–30,583–0.00%–
 Download
Other shareholders

There were no reported owners of BIONDVAX PHARMACEUTICALS LTD in Q1 2022.

NameSharesValueWeighting ↓
View complete list of BIONDVAX PHARMACEUTICALS LTD shareholders